Ken-ichiro Tanaka

Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells

Ken-ichiro Tanaka, Toru Yamaguchi, Ippei Kanazawa et al. · Biochemical and Biophysical Research Communications · 2015 · 172 citations

Sclerostin, High Glucose, Bone Morphogenic Protein +12

Immunohistochemical Expression of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Atherosclerotic Intimas of Human Coronary Arteries

Yong‐Xiang Chen, Yutaka Nakashima, Ken-ichiro Tanaka et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 124 citations

Vascular Disease, Immunology, Pathology +23

Role of Osteoglycin in the Linkage between Muscle and Bone

Ken-ichiro Tanaka, Erika Matsumoto, Yoshiko Higashimaki et al. · Journal of Biological Chemistry · 2012 · 119 citations · Full text

Advanced Glycation End Products (AGEs), but not High Glucose, Inhibit the Osteoblastic Differentiation of Mouse Stromal ST2 Cells Through the Suppression of Osterix Expression, and Inhibit Cell Growth and Increasing Cell Apoptosis

Kyoko Okazaki, Toru Yamaguchi, Ken-ichiro Tanaka et al. · Calcified Tissue International · 2012 · 96 citations

Osteoblastic Differentiation, Developmental Biology, High Glucose +9

Active vitamin D possesses beneficial effects on the interaction between muscle and bone

Ken-ichiro Tanaka, Ippei Kanazawa, Toru Yamaguchi et al. · Biochemical and Biophysical Research Communications · 2014 · 66 citations

Bone Disease, Bone Health, Beneficial Effects +10